Awareness, Care & Treatment In Obesity Management - An Observation in Switzerland

CompletedOBSERVATIONAL
Enrollment

1,152

Participants

Timeline

Start Date

March 8, 2022

Primary Completion Date

April 8, 2022

Study Completion Date

April 8, 2022

Conditions
Obesity
Interventions
OTHER

No treatment given

No treatment given

Trial Locations (1)

Unknown

Novo Nordisk Investigational Site, Zurich

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT05232786 - Awareness, Care & Treatment In Obesity Management - An Observation in Switzerland | Biotech Hunter | Biotech Hunter